SB 659032

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB 659032, covering 2012-12-10 to 2012-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effect of SB 659032 on Platelet Function [Phase 1]